Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2026-02-27 @ 4:33 PM
Study NCT ID:
NCT03307759
Status:
TERMINATED
Last Update Posted:
2025-09-15
First Post:
2017-10-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma
Sponsor:
Peter MacCallum Cancer Centre, Australia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SABRseq
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None